VJHemOnc is committed to improving our service to you

EBMT 2020 | Mutational profiles of MDS patients undergoing allo-HSCT

VJHemOnc is committed to improving our service to you

Ivan Moiseev

Ivan Moiseev, MD, PhD, First Saint Petersburg State Medical University, Saint Petersburg, Russia, discusses the outcomes and mutational profile of patients with myelodysplastic syndromes (MDS) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter